Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:03:07 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - http://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.1325+0.0032.3290.135560.129  0.13275  0.1270.21  0.029115:59:50Feb 1415 min RT 2¢

Recent Trades - Last 10 of 56
Time ETExPriceChangeVolume
15:59:50Q0.13250.003500
15:44:20Q0.13250.003500
15:43:20Q0.131250.00175650
15:35:19Q0.13250.003100
15:19:06Q0.13080.00131,000
15:19:06Q0.1308750.00137519,314
13:32:37Q0.13250.003500
13:29:04Q0.130.000547,500
13:28:53Q0.131250.001752,500
12:55:59Q0.13250.003500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-02-14 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
2024-02-08 08:16U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
2023-12-26 07:07U:ELTPNews ReleaseElite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
2023-12-12 07:04U:ELTPNews ReleaseElite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
2023-11-14 17:36U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
2023-11-10 11:32U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
2023-09-25 06:01U:ELTPNews ReleaseElite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
2023-09-07 06:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
2023-08-28 06:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2023-08-14 16:46U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
2023-08-09 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
2023-06-29 17:10U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
2023-06-22 06:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
2023-05-03 06:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer